Previsioni
Il prezzo obiettivo medio degli analisti è 1,82 € (-6,67%). La mediana è 1,82 € (-6,67%).
| Acquista |
8 |
| Mantieni |
4 |
| Vendi |
1 |
Discussioni nella community
Non ci sono ancora discussioni su questo asset.
Avvia discussioneNotizie Vai al feed delle notizie
Accuray reports mixed Q4 results: revenue weaker, stock under pressure
Accuray slightly beat adjusted loss guidance with EPS of -$0.02 in Q4 but missed revenue estimates with $100.91 million (‑21% year over year). Product revenue plunged 42% in the quarter, while the service business grew 6% and gross margin improved to 34.8%. Management declined to give formal guidance for 2027 due to geopolitical and tariff-related uncertainties, but announced cost cuts, service growth initiatives and a debt-conversion transaction. The stock fell sharply after the results, and the company’s market position remains weighed down by high debt and persistently weak device sales. » Altro su de.investing.com
Accuray withdraws full-year guidance after weak quarter and cites geopolitical turbulence
Accuray reported Q3 revenue of $104.8 million (-7%), missed expectations, and recorded adjusted EBITDA of $3.8 million with a GAAP net loss of $11.8 million. The stock fell in after-hours trading and is trading near its 52-week low. Management cites conflicts in the Middle East, uncertainties in China and tariff debates as reasons and has withdrawn the 2026 full-year guidance. The company meanwhile emphasizes ongoing transformation measures with already realized margin improvements and expects further cost improvements for 2027. » Altro su de.investing.com
Accuray adjusts advisory agreement and cuts cash compensation by 50% to reduce costs
Accuray amended the advisory agreement with Dedication Capital (connected to director Steven F. Mayer): cash fees and minimum premiums for certain periods were reduced by 50%, expected to save at least $362,500. Time-based vesting conditions for 916,336 restricted shares and all performance share awards were deemed satisfied as of April 1; 333,004 remaining shares are scheduled to be issued on October 31, 2026, and the agreement’s termination date was extended to October 31, 2026. The adjustment comes against the backdrop of high debt of $174 million and a market capitalization of $49.75 million; the stock lost 73% in six months but recently gained about 8%. Additionally, Accuray reported Q2 revenue of $102.2 million (below expectations) with EPS of -$0.11, BTIG cut its price target from $4 to $2, and NASDAQ flagged ongoing minimum-price violations. » Altro su de.investing.com
Accuray reports 12% revenue decline in Q2 FY26 and lowers full-year guidance
Accuray reported Q2 FY26 revenue of $102.2 million (-12%), with product revenue down 26% to $45.0 million and service revenue up 4% to $57.2 million. Gross margin fell to 23.5% and adjusted EBITDA declined to -$1.9 million. Shipments through the China joint venture dropped sharply (11 vs. 27 units), weighing on reporting and margins. The company cut its full-year guidance to $440–450 million in revenue and $22–25 million in adjusted EBITDA, and plans $13 million in restructuring charges and a 15% workforce reduction. » Altro su de.investing.com
Accuray: board member Byron C. Scott to resign effective December 31, 2025
Byron C. Scott has announced his resignation from Accuray’s board of directors, effective December 31, 2025. In a filing with the SEC, the company said the resignation is not due to any disagreements with Accuray or its boards. No other changes to the board or management were disclosed. » Altro su de.investing.com
Dividendi storici Dividendi
Tutte le metriche sui dividendi Tutte le metricheNel 2022, Accuray ha già distribuito 0,62 € di dividendi. L'ultimo pagamento è avvenuto a giugno 2022.
Dati finanziari
Nell'ultimo trimestre, Accuray ha registrato ricavi pari a 76,39 Mln € e un utile netto di 8,95 Mln €
| (EUR) | settembre 2026 | YoY |
|---|---|---|
| Ricavi | 76,39 Mln | 4,58% |
| Utile lordo | 23,03 Mln | 1,79% |
| Utile netto | 8,95 Mln | 148,43% |
| EBITDA | 19,85 Mln | 302,89% |
Dati fondamentali
| Metrica | Valore |
|---|---|
Capitalizzazione di mercato | 6,83 Mln € |
Numero di azioni | 3 Mln |
Massimo/minimo a 52 settimane | 41,19 € - 2,17 € |
| Dividendi | No |
Beta | 1,38 |
Rapporto P/E | -0,43 |
Rapporto PEG | 0,01 |
Rapporto P/B | 0,16 |
Rapporto P/S | 0,02 |
Profilo aziendale
Accuray Incorporated progetta, sviluppa, produce e vende sistemi di radiochirurgia e radioterapia per il trattamento dei tumori nelle Americhe, in Europa, in Medio Oriente, in India, in Africa, in Giappone, in Cina e nel resto della regione Asia-Pacifico. Offre il sistema CyberKnife, un sistema robotico di radiochirurgia stereotassica e di radioterapia stereotassica corporea utilizzato per il trattamento di diversi tipi di cancro e tumori del corpo, come quelli della prostata, del polmone, del cervello, della colonna vertebrale, del fegato, del pancreas e del rene. La società fornisce inoltre il sistema TomoTherapy, incluso il sistema Radixact, che consiste in un sistema integrato di radioterapia progettato per il trattamento di una serie di tipi di cancro. Inoltre, offre assistenza clienti post-contratto, installazione, formazione e altri servizi professionali. La società commercializza i propri prodotti principalmente in modo diretto ai clienti, inclusi ospedali e strutture di trattamento indipendenti, attraverso la propria organizzazione di vendita, nonché ai clienti tramite agenti di vendita e organizzazioni di acquisto di gruppo negli Stati Uniti; e ai clienti direttamente e tramite distributori e agenti di vendita a livello internazionale. Accuray Incorporated è stata costituita nel 1990 e ha sede a Sunnyvale, in California.
| Nome | Accuray |
| CEO | Stephen R. LaNeve |
| Sede centrale | Madison,
wi Stati Uniti |
| Sito web | |
| Settore | Beni voluttuari |
| Industria | Beni durevoli per la casa |
| Quotazione in borsa | 08/02/2007 |
| Dipendenti | 809 |
Deep Dive
Simboli di borsa
| Borsa | Simbolo |
|---|---|
NASDAQ | ARAY |
London Stock Exchange | 0H8I.L |
Frankfurt | XEJ.F |
Düsseldorf | XEJ.DU |
London | 0H8I.L |
SIX | XEJ.SW |
München | XEJ.MU |